The molecular profiling of breast cancer is heterogenous, which can be classified based on the expression of estrogen receptor (ER) or progesterone receptor, and human epidermal growth factor receptor 2 (Her2) (Hondermarck et al., 2001). This evidence concerns the gene ERBB2 and breast cancer.